These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 10576378

  • 1. The prevalence of gallstones in chronic liver disease is related to degree of liver dysfunction.
    Elzouki AN, Nilsson S, Nilsson P, Verbaan H, Simanaitis M, Lindgren S.
    Hepatogastroenterology; 1999; 46(29):2946-50. PubMed ID: 10576378
    [Abstract] [Full Text] [Related]

  • 2. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A, Guaqueta C, Molina EG, Conrad A, Mishra V, Brantly ML, Torres M, De Medina M, Tzakis AG, Schiff ER.
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of gallstones in liver cirrhosis: a sonographic survey.
    Acalovschi M, Badea R, Dumitraşcu D, Varga C.
    Am J Gastroenterol; 1988 Sep; 83(9):954-6. PubMed ID: 3046336
    [Abstract] [Full Text] [Related]

  • 4. Cholelithiasis in cirrhosis: analysis of 500 cases.
    Conte D, Barisani D, Mandelli C, Bodini P, Borzio M, Pistoso S, Segala M, Aimo GP, Fraquelli M, Bianchi PA.
    Am J Gastroenterol; 1991 Nov; 86(11):1629-32. PubMed ID: 1951241
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study.
    Acalovschi M, Blendea D, Feier C, Letia AI, Ratiu N, Dumitrascu DL, Veres A.
    Am J Gastroenterol; 2003 Aug; 98(8):1856-60. PubMed ID: 12907344
    [Abstract] [Full Text] [Related]

  • 6. Cholelithiasis in patients with chronic active liver disease: evaluation of risk factors.
    Castellano L, De Sio I, Silvestrino F, Marmo R, Del Vecchio Blanco C.
    Ital J Gastroenterol; 1995 Aug; 27(8):425-9. PubMed ID: 8775468
    [Abstract] [Full Text] [Related]

  • 7. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
    Stroffolini T, Sagnelli E, Mele A, Cottone C, Almasio PL, Italian Hospitals' Collaborating Group.
    J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?
    Thakur V, Guptan RC, Malhotra V, Basir SF, Sarin SK.
    J Assoc Physicians India; 2002 Nov; 50():1386-94. PubMed ID: 12583467
    [Abstract] [Full Text] [Related]

  • 9. [Cholelithiasis in patients with liver cirrhosis].
    Ichiyanaqui C, Monge E, Huamán C, Flores C, Beteta O, Soto W.
    Rev Gastroenterol Peru; 1996 Nov; 16(1):43-7. PubMed ID: 8664486
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of cholelithiasis in alcoholic and genetic haemochromatotic cirrhosis.
    Conte D, Barisani D, Mandelli C, Fargion S, Fracanzani AL, Cesarini L, Bodini P, Pistoso S, Bianchi PA.
    Alcohol Alcohol; 1993 Sep; 28(5):581-4. PubMed ID: 8274182
    [Abstract] [Full Text] [Related]

  • 11. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
    Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E, Podestà E, Chiarbonello B, Polegato S, Mamone M, Testa R.
    Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
    [Abstract] [Full Text] [Related]

  • 12. Autonomic function in chronic liver disease assessed by Heart Rate Variability Study.
    Coelho L, Saraiva S, Guimaräes H, Freitas D, Providência LA.
    Rev Port Cardiol; 2001 Jan; 20(1):25-36. PubMed ID: 11291332
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
    Fisher L, Fisher A.
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
    [Abstract] [Full Text] [Related]

  • 14. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
    Hodges JR, Millward-Sadler GH, Barbatis C, Wright R.
    N Engl J Med; 1981 Mar 05; 304(10):557-60. PubMed ID: 6969850
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep 05; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 16. A necroptic study of the prevalence of cholelithiasis in liver cirrhosis.
    Acalovschi M, Dumitraşcu D, Ban A, Petrescu A.
    Med Interne; 1986 Sep 05; 24(1):23-7. PubMed ID: 3704500
    [Abstract] [Full Text] [Related]

  • 17. Soluble P selectin levels in chronic liver disease: relationship to disease severity.
    Vardareli E, Saricam T, Demirustu C, Gulbas Z.
    Hepatogastroenterology; 2007 Mar 05; 54(74):466-9. PubMed ID: 17523300
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of gallstone disease in patients with end-stage renal disease treated with hemodialysis in Korea.
    Hahm JS, Lee HL, Park JY, Eun CS, Han DS, Choi HS.
    Hepatogastroenterology; 2003 Mar 05; 50(54):1792-5. PubMed ID: 14696406
    [Abstract] [Full Text] [Related]

  • 19. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency.
    Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK.
    Hepatology; 1998 Oct 05; 28(4):1058-63. PubMed ID: 9755243
    [Abstract] [Full Text] [Related]

  • 20. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
    Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, Lee PC, Tsay SH, Lee SD.
    Hepatogastroenterology; 2002 Oct 05; 49(44):478-81. PubMed ID: 11995477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.